Amanda Parkes, MD
University of Wisconsin
Dr. Amanda Parkes is an Assistant Professor at the University of Wisconsin, with a medical oncology practice focused on sarcoma and breast cancer patients. She completed her Medical Degree at the University of Wisconsin School of Medicine and Public Health, and pursued residency in Internal Medicine at Massachusetts General Hospital, followed by Hematology and Oncology fellowship at MD Anderson Cancer Center. She is highly invested in medical education at all levels, serving as Associate Program Director of the University of Wisconsin Hematology and Medical Oncology Fellowship program and Course Director of the Medical Oncology Elective Rotation for medical students and residents. Dr. Parkes is also invested in medical education research, currently conducting a project to improve the development and support of research skills in fellowship training.
Anthony Charles Bejjani, MD
UCLA Medical Center
Dr. Anthony Bejjani earned his medical degree from SUNY Buffalo in 2014. He gained recognition for mentorship and tutoring of his fellow medical students with the James Goldinger Curriculum Leadership Award. He completed his internal medicine residency at UCLA in 2017. He further expanded his interest in medical education during residency by participating in the inaugural year of the medical education pathway for residents. He formulated simulations from case for a capstone course for the graduating medical students and devised an oncology case for a high-value case series.
Dr. Bejjani will be completing his fellowship at UCLA in June 2020. He was recognized as fellow teacher of the year in his first year and plans to focus on medical education in his career. His other career interests include research in hepatobiliary malignancies, hematology/oncology curriculum development, and mentorship of residents and fellows.
Aparna Parikh, MD
Massachusetts General Hospital
Dr. Parikh is faculty at MGH Cancer Center. She was a resident at MGH, oncology fellow at UCSF and briefly worked at Genentech before returning to academic medicine. She focuses on gastrointestinal cancers, particularly colorectal and pancreatic cancer with the goal of harnessing novel strategies, including immunotherapy approaches to improve outcomes. She also leads the clinical efforts of the liquid biopsy program that is a cornerstone of the GI program. The team is using liquid biopsies as a platform for understanding heterogeneous resistance mechanisms, tracking treatment response and in minimal residual disease. She is PI of a large, multi-institutional Stand Up 2 Cancer trial using liquid biopsies to guide adjuvant in colon cancer. She has received funding from ACS, NCI GI Spore, Gateway Foundation and Stand up 2 Cancer. She also was named a Barry Scholar at MGH, a fellowship that supports junior faculty and most recently received the ASCO Career Development Award.
Besides a robust clinical investigator and teaching role, she has maintained a passion for cancer in the developing world after several international experiences over the years and co-directs an initiative that is bringing trainees from Sub-Saharan Africa to Boston to help enhance their medical oncology training. She also directs the teaching curriculum for the DFCI/Harvard Cancer Center Oncology Fellows as they do GI oncology at MGH.
Dr. Parikh’s passion is caring for patients while teaching, mentoring and engaging in cutting-edge science in hopes of moving the needle for cancer patients in the United States and across the globe. She is thrilled to be selected for the prestigious ASCO Education Scholars program.
Kelechi Eguzo, MD, MPH, GPO
University of Saskatchewan
Dr. Kelechi Eguzo is a General Practitioner in Oncology and researcher best known for his book, ‘Where there is no Oncologist. He is affiliated with the University of Saskatchewan, Nigerian Christian Hospital and Marjorie Bash Foundation. Since 2015, Dr. Eguzo has led several ASCO training courses on cancer control in Nigeria. His research focuses on capacity building for local health professionals, development of local clinical pathways and patient navigation systems, as well as medical education. Dr. Eguzo seeks to improve cancer control in Nigeria, especially by establishing Marjorie Bash Cancer Center in Aba. Through his work on cancer control, Kelechi has earned awards from the American Society of Clinical Oncology (ASCO), Union for International Cancer Control and Cancer Research UK (CRUK). He is married with four children, all of whom keep him busy in his ‘spare time’.
Jennifer J. Gao, MD
U.S. Food and Drug Administration
Dr. Jennifer Gao is a medical oncologist and the Acting Associate Director for Education in the Oncology Center of Excellence (OCE) at the U.S. Food & Drug Administration (FDA). She received her undergraduate degree from Harvard University and spent a year in Bonn, Germany, as a J. William Fulbright Fellow before completing her medical degree at the Alpert Medical School of Brown University. She pursued her internal medicine internship and residency training at Massachusetts General Hospital, followed by a fellowship in medical oncology at the National Cancer Institute (NCI), where she also served as Chief Fellow. In 2016, Dr. Gao joined the FDA as a physician on the breast cancer team. She served as the Acting Breast Team Lead before assuming her current position as the lead of Project Socrates, spearheading the OCE’s efforts of building an educational network to bridge oncology drug development, regulatory science, and policy from the OCE to the public.
Dr. Gao’s clinical focus is in breast cancer and she continues to see patients at Georgetown Lombardi Comprehensive Cancer Center. An ASCO member since 2013, Dr. Gao has served on the ASCO Professional Development Committee, Technology Research Group, Publishing Research Group, and Learning Cohort.
Elizabeth Henry, MD
Loyola University Medical Center
Dr. Elizabeth Henry graduated magna cum laude from Vassar College in 2001 with a BA in Science, Technology and Society. She earned her MD from Loyola University Stritch School of Medicine. She completed her clinical training at Loyola Medical Center and served as chief fellow in hematology/oncology. Upon graduation, Dr. Henry stayed on as clinical faculty at Loyola Medical Center and Hines VA Hospital specializing in genitourinary cancers. She is currently an Associate Professor in the Department of Medicine, and the program director of the hematology/oncology fellowship program at Loyola. Dr. Henry was recently honored as a faculty inductee to AOA.
Dr. Henry's clinical research focuses on novel therapeutic strategies in bladder and prostate cancers. She leads the GU oncology research collaborative at LUMC. She also has a passion for medical education research, with projects focusing on the use of social media as a novel platform in medical education, and strategies to build community and reduce grief and empathy loss amongst medical trainees in oncology. Follow her on Twitter @DocLHenry.
Jiping Wang, MD, PhD
Brigham and Women's Hospital
Dr. Jiping Wang is a surgical oncologist, biostatistician, and medical educator. He is an associate professor at Harvard Medical School and attending physician at Gastrointestinal cancer center and Sarcoma treatment center at Dana Farber/Brigham and Women’s Cancer Center. Before his surgical oncology training, Dr. Wang obtained his Ph.D. from University of Pittsburgh in Biostatistics and served as a statistician at NSABP for five years. He developed a statistical course “Anatomy of Biostatistics” for clinicians at State University of New York at Buffalo. Dr. Wang is the founding and chief editor of "Art of Surgery", a surgical education online journal.
Dr. Wang’s clinical practice focuses on soft tissue sarcoma, hepatobiliary, pancreases, and gastric cancers. He is an advocator for the minimally invasive approach for gastric and pancreatic cancer. He also developed modules and quality measures for gastric cancer surgery training.
Malcolm Mattes, MD
Dr. Malcolm Mattes is a New Jersey native who recently moved back to his home state after spending 5 years practicing at West Virginia University. He is currently an associate professor in radiation oncology with a strong interest in improving multidisciplinary education of physicians who treat cancer patients in order to optimize patient-centered care. He has published 45 peer-reviewed articles, many in the realm of medical education, and has conducted several investigator-initiated clinical trials in the areas of immuno-oncology, cancer metabolism, and personalized medicine. His prior training has included college at MIT, medical school at UCLA, internship at Stanford, and residency at New York Methodist Hospital.
Martina Murphy, MD
University of Florida
Dr. Martina Murphy is a clinical investigator and medical educator specializing in gynecologic cancer. Her research focuses in the study and reduction of healthcare disparities & inequity as it pertains to patient-related outcomes as well as workplace and training environments. She serves as the Program Director for the adult Hematology/Oncology Fellowship Program at the University of Florida, course director for the MS1 Introduction to Clinical Medicine and a longitudinal mentor within the UFCOM Collaborative Learning Group curriculum. Amongst other work, she was the lead on the development and implementation of an implicit bias curriculum for UF Heme/Onc fellows which helped initiate an institutional push for professional bias training for healthcare professionals. She is interested and actively involved at a national level in research in medical education primarily related to novel curriculum development.
Dr. Murphy is board certified in Internal Medicine, Hematology and Oncology and is a member of the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH) and is an active member of the ASH Committee on Training as well as a faculty mentor within the ASH Medical Educators Institute.
Maura Barry, MD
University of Vermont
Dr. Maura “Molly” Barry is an assistant professor of medicine at the University of Vermont. She earned her undergraduate degree from Barnard College in 2002 and her medical degree from New Jersey Medical School in 2007. She completed her Internal Medicine residency and chief residency at New Jersey Medical School and fellowship in Hematology/Oncology at New York University. She has been on faculty as an Assistant Professor at the Larner College of Medicine at the University of Vermont since 2014. Her clinical work focuses on GI and head and neck oncology, with an interest in research focusing on quality of life and supportive care.
Dr. Barry’s professional passion is to promote excellence in oncology education and enhance professional satisfaction by making education accessible and exciting. She is Associate Program Director of the Hematology/Oncology fellowship program, a member of the Larner College of Medicine Teaching Academy, and serves as a question reviewer for ASCO eLearning.
Prakash Neupane, MBBS
University of Kansas Medical Center
Dr. Prakash Neupane is associate professor and director of Hematology-Oncology Fellowship at the University of Kansas medical Center.
Dr. Neupane complete medical school in Nepal and moved to New York for internal medicine residency. After residency, completed hematology oncology fellowship at Louisiana State University, Shreveport. After initial two years clinical faculty position, Dr. Neupane moved to a small community practice. Five years later, Dr Neupane joined the University of Kansas Medical Center as an assistant professor.
Last ten years, Dr, Neupane’s clinical focus is head and neck and thoracic oncology. Dr. Neupane is involved in teaching of residents and fellows as an associate program director for seven years. Dr. Neupane became program director for hematology oncology fellowship in 2017.
Dr. Neupane has organized many annual conferences and symposiums as a course director. Dr. Neupane is active as ASCO international volunteer as IDEA mentor, MCMC course director and HVO /ASCO volunteer including HVO project director for Kathmandu Medical Oncology program.
Santhosh Thyagu, MBBS, MD, DNB, DM
Princess Margaret Cancer Center
Dr. Santhosh Thyagu is a hematologist/medical oncologist at the Princess Margaret Cancer Center and an Assistant Professor with the University of Toronto. After being a staff with the leukemia and allogenic hematopoietic stem cell transplantation services, he leads the Acute Oncology Program at the institution. As a clinician teacher, Dr. Thyagu invests himself heavily in medical education: multi-level teaching at the University, patient and caregiver education, and as the site coordinator for postgraduate hematology rotation at the UHN and Mount Sinai. He transformed a service oriented urgent care clinic in his institution into a sought-after educational hub imparting hands-on training to a variety of learners. He is the recipient of several teaching and humanitarian awards. He is a member of the Education Committee and is the physician liaison for the Patient and Family special interest group of the Cell Therapy Transplant Canada (CTTC). He passionately looks forward to advancing the Acute Oncology Program that he leads, into an educational and research powerhouse in his institution and beyond.